ROSGQ Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings for Rosetta Genomics Ltd (ROSGQ)

Based on 9 analysts giving stock ratings to Rosetta Genomics Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
Rosetta Genomics Ltd

Rosetta Genomics Ltd. Stock Analysis ROSGQ

United States Health Care Nano Cap
Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.
Read More

ROSGQ Chart

Key Statistics of Rosetta Genomics Ltd (ROSGQ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

117.00

P/E Ratio (TTM)

-

52 Week Range

$0$0.00

Market Cap

600.00

Avg. Volume

16.18K

Dividend Yield

-

Financial Metrics & Statements of Rosetta Genomics Ltd (ROSGQ)

  • Per Share Data
  • Ratios
  • Statements
No data

No Data Available!

  • Annual Icon Annual
  • Quarterly Icon Quarterly
No data

No Annual Data Available!

FAQ's for Rosetta Genomics Ltd (ROSGQ)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.